Endobronchial Ultrasound Biopsy Market Size, Share & Trends Analysis Report By Product (EBUS Scopes, EBUS Needles, Convex EBUS, Radial EBUS), By Procedures, By End Use, By Region, And Segment Forecasts, 2025 - 2033
Description
Endobronchial Ultrasound Biopsy Market Summary
The global endobronchial ultrasound biopsy market size was estimated at USD 728.6 million in 2024 and is projected to reach USD 1,186.5 million by 2033, growing at a CAGR of 6.30% from 2025 to 2033. This growth can be attributed to the rising prevalence of cancer, increasing technological advancements in endobronchial ultrasound (EBUS) technology, the growing geriatric population, the growing prevalence of respiratory diseases, and the increasing adoption of minimally invasive procedures.
According to the WHO, the global elderly population aged 60 years and above is expected to increase from around 1.1 billion in 2021 to 1.4 billion in 2030. The increasing prevalence of lung cancer drives market growth as it is one of the leading causes of cancer-related deaths worldwide, with rising incidence rates attributed to factors such as smoking, air pollution, and occupational hazards. For instance, the American Cancer Society projects that in 2025, there will be approximately 226,650 new lung cancer cases in the U.S., with 110,680 cases occurring in men and 115,970 in women. In addition, it is estimated that there will be around 124,730 deaths due to lung cancer, comprising 64,190 men and 60,540 women. As early and accurate diagnosis is critical for improving patient outcomes, there is a growing demand for minimally invasive procedures such as EBUS-guided biopsy. This technique allows for precise sampling of lymph nodes and lung lesions, allowing early-stage detection and staging of lung cancer.
Furthermore, the rising prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), tuberculosis, and others, significantly contributes to the market growth. As these conditions become more widespread due to factors such as smoking, air pollution, and aging populations, the demand for minimally invasive diagnostic procedures has increased. In addition, advancements in EBUS technology, including better imaging resolution and real-time needle guidance, enhance diagnostic efficiency and further improve its adoption among healthcare providers.
Global Endobronchial Ultrasound Biopsy Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global endobronchial ultrasound biopsy market report based on product, procedure, end use, and region:
The global endobronchial ultrasound biopsy market size was estimated at USD 728.6 million in 2024 and is projected to reach USD 1,186.5 million by 2033, growing at a CAGR of 6.30% from 2025 to 2033. This growth can be attributed to the rising prevalence of cancer, increasing technological advancements in endobronchial ultrasound (EBUS) technology, the growing geriatric population, the growing prevalence of respiratory diseases, and the increasing adoption of minimally invasive procedures.
According to the WHO, the global elderly population aged 60 years and above is expected to increase from around 1.1 billion in 2021 to 1.4 billion in 2030. The increasing prevalence of lung cancer drives market growth as it is one of the leading causes of cancer-related deaths worldwide, with rising incidence rates attributed to factors such as smoking, air pollution, and occupational hazards. For instance, the American Cancer Society projects that in 2025, there will be approximately 226,650 new lung cancer cases in the U.S., with 110,680 cases occurring in men and 115,970 in women. In addition, it is estimated that there will be around 124,730 deaths due to lung cancer, comprising 64,190 men and 60,540 women. As early and accurate diagnosis is critical for improving patient outcomes, there is a growing demand for minimally invasive procedures such as EBUS-guided biopsy. This technique allows for precise sampling of lymph nodes and lung lesions, allowing early-stage detection and staging of lung cancer.
Furthermore, the rising prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), tuberculosis, and others, significantly contributes to the market growth. As these conditions become more widespread due to factors such as smoking, air pollution, and aging populations, the demand for minimally invasive diagnostic procedures has increased. In addition, advancements in EBUS technology, including better imaging resolution and real-time needle guidance, enhance diagnostic efficiency and further improve its adoption among healthcare providers.
Global Endobronchial Ultrasound Biopsy Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global endobronchial ultrasound biopsy market report based on product, procedure, end use, and region:
- Product Outlook (Revenue, USD Million, Unit Volume (shipments), Installed Base (units in-use) 2021 - 2033)
- EBUS Scopes
- Convex Convex-probe (Linear / CP-EBUS) Scopes
- Convex-probe (Linear / CP-EBUS) Scopes
- EBUS-TBNA Needles & Dedicated Biopsy Consumables
- Ultrasound Processors and Imaging Systems
- Accessories & Ancillaries (sheaths, forceps, adapters, sterilization consumables)
- Procedure Outlook (Procedure Volume, in ‘000 Procedures, 2021 - 2033)
- EBUS Scopes
- Convex-probe (Linear / CP-EBUS) Scopes
- By indication
- Lung Cancer Staging
- Sarcoidosis/Others
- Radial-probe (RP-EBUS) Scopes
- EBUS-TBNA Needles & Dedicated Biopsy Consumables
- End-use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Community Hospitals
- Academic/Teaching Hospitals
- Large Multispecialty Hospitals/Networks
- Ambulatory Surgical Centers (ASCs)
- Independent ASCs
- Hospital-Affiliated ASCs
- Specialty Clinics
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
190 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Procedure
- 1.2.3. End use
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR’s Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising incidence of lung cancer and respiratory disorders
- 3.2.1.2. Increased innovation in EBUS bronchoscopes and strengthening market leadership
- 3.2.1.3. Shift toward minimally invasive diagnostics
- 3.2.1.4. Favorable reimbursement and clinical guidelines
- 3.2.1.5. Government-led lung cancer screening programs
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. The high cost of EBUS systems and associated procedures
- 3.2.2.2. Requirement for highly skilled professionals
- 3.2.3. Industry Opportunity Analysis
- 3.2.4. Industry Challenge Analysis
- 3.2.5. Case Studies
- 3.3. Business Environment Analysis
- 3.3.1. Porter’s Five Forces Analysis
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental landscape
- 3.3.2.5. Legal Landscape
- Chapter 4. Endobronchial Ultrasound Biopsy Market: Product Estimates & Trend Analysis
- 4.1. Product Segment Dashboard
- 4.2. Product Market Share Movement Analysis, 2024 & 2033
- 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
- 4.4. EBUS Scopes
- 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million
- 4.4.2. Market Unit Volume Estimates and Forecasts, 2021 - 2033 (shipments)
- 4.4.3. Market Installed Base Estimates and Forecasts, 2021 - 2033
- 4.4.4. Convex Probe EBUS Convex-probe (Linear / CP-EBUS) Scopes
- 4.4.4.1. Healthcare Institutions Utilizing Convex Probe Endobronchial Ultrasound (CP-EBUS) Systems
- 4.4.4.2. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.4.3. Market Unit Volume Estimates and Forecasts, 2021 - 2033 (shipments)
- 4.4.4.4. Market Installed Base Estimates and Forecasts, 2021 - 2033
- 4.4.5. Radial-probe (RP-EBUS) Scopes
- 4.4.5.1. Healthcare Institutions Utilizing Convex Probe Endobronchial Ultrasound (CP-EBUS) Systems
- 4.4.5.2. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.5.3. Market Unit Volume Estimates and Forecasts, 2021 - 2033 (shipments)
- 4.4.5.4. Market Installed Base Estimates and Forecasts, 2021 - 2033
- 4.5. EBUS-TBNA Needles & Dedicated Biopsy Consumables
- 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.2. Market Unit Volume Estimates and Forecasts, 2021 - 2033 (annual consumables/needles)
- 4.6. Ultrasound Processors and Imaging Systems
- 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.2. Market Unit Volume Estimates and Forecasts, 2021 - 2033 (shipments)
- 4.7. Accessories & Ancillaries (sheaths, forceps, adapters, sterilization consumables)
- 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.7.2. Market Unit Volume Estimates and Forecasts, 2021 - 2033 (annual consumption)
- 4.8. ASP & Service Metrics (U.S., EU5, ANZ, Japan)
- 4.8.1. Average Selling Prices of EBUS Scopes (by subtype)
- 4.8.2. Typical Service Contracts (% of install base, avg. annual cost)
- 4.8.3. Replacement Cycles and Refurbishment Trends
- Chapter 5. Endobronchial Ultrasound Biopsy Market: Procedure Estimates & Trend Analysis
- 5.1. Procedure Dashboard
- 5.2. Procedure Market Share Movement Analysis, 2024 & 2033
- 5.3. Procedure Volume & Forecasts and Trend Analysis, by Procedure, 2021 to 2033 (in ‘000 Procedures)
- 5.4. EBUS Scopes
- 5.4.1. Procedure Volume - Market Estimates & Forecasts, 2021 - 2033 (in ‘000 Procedures)
- 5.4.2. Convex-probe (Linear / CP-EBUS) Scopes
- 5.4.2.1. Procedure Volume - Market Estimates & Forecasts, 2021 - 2033 (in ‘000 Procedures)
- 5.4.2.2. Lung Cancer Staging
- 5.4.2.2.1.1. Procedure Volume - Market Estimates & Forecasts, 2021 - 2033 (in ‘000 Procedures)
- 5.4.2.3. Sarcoidosis/Others
- 5.4.2.3.1.1. Procedure Volume - Market Estimates & Forecasts, 2021 - 2033 (in ‘000 Procedures)
- 5.4.3. Radial-probe (RP-EBUS) Scopes
- 5.4.3.1.1. Procedure Volume - Market Estimates & Forecasts, 2021 - 2033 (in ‘000 Procedures)
- 5.5. EBUS-Transbronchial Needle Aspiration (EBUS-TBNA)
- 5.5.1. Procedure Volume - Market Estimates & Forecasts, 2021 - 2033 (in ‘000 Procedures)
- 5.6. EBUS-Guided Biopsy
- 5.6.1. Procedure Volume - Market Estimates & Forecasts, 2021 - 2033 (in ‘000 Procedures)
- Chapter 6. Endobronchial Ultrasound Biopsy Market: End Use Estimates & Trend Analysis
- 6.1. End Use Segment Dashboard
- 6.2. End Use Market Share Movement Analysis, 2024 & 2033
- 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 6.4. Hospitals
- 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.2. Community Hospitals (Typically 100-300 beds, serving local/regional populations.)
- 6.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.3. Academic/Teaching Hospitals [500+ beds, often part of academic medical networks.
- 6.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.4. Large Multispecialty Hospitals/Networks (300-500+ beds, often part of integrated delivery networks (IDNs).
- 6.4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Ambulatory Surgical Centers (ASCs)
- 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.2. Independent ASCs
- 6.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.3. Hospital-Affiliated ASCs
- 6.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Specialty Clinics
- 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 7. Endobronchial Ultrasound Biopsy Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Dashboard
- 7.2. Regional Market: Key Takeaways
- 7.3. North America
- 7.3.1. North America Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key country dynamic
- 7.3.2.2. Regulatory framework
- 7.3.2.3. Competitive insights
- 7.3.2.4. U.S. Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key country dynamic
- 7.3.3.2. Regulatory framework
- 7.3.3.3. Competitive insights
- 7.3.3.4. Canada Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key country dynamic
- 7.3.4.2. Regulatory framework
- 7.3.4.3. Competitive insights
- 7.3.4.4. Mexico Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4. Europe
- 7.4.1. Europe Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.2. Germany
- 7.4.2.1. Key country dynamic
- 7.4.2.2. Regulatory framework
- 7.4.2.3. Competitive insights
- 7.4.2.4. Germany Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.3. UK
- 7.4.3.1. Key country dynamic
- 7.4.3.2. Regulatory framework
- 7.4.3.3. Competitive insights
- 7.4.3.4. UK Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key country dynamic
- 7.4.4.2. Regulatory framework
- 7.4.4.3. Competitive insights
- 7.4.4.4. France Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key country dynamic
- 7.4.5.2. Regulatory framework
- 7.4.5.3. Competitive insights
- 7.4.5.4. Italy Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key country dynamic
- 7.4.6.2. Regulatory framework
- 7.4.6.3. Competitive insights
- 7.4.6.4. Spain Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.7. Denmark
- 7.4.7.1. Key country dynamic
- 7.4.7.2. Regulatory framework
- 7.4.7.3. Competitive insights
- 7.4.7.4. Denmark Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.8. Sweden
- 7.4.8.1. Key country dynamic
- 7.4.8.2. Regulatory framework
- 7.4.8.3. Competitive insights
- 7.4.8.4. Sweden Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.9. Norway
- 7.4.9.1. Key country dynamic
- 7.4.9.2. Regulatory framework
- 7.4.9.3. Competitive insights
- 7.4.9.4. Norway Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.2. Japan
- 7.5.2.1. Key country dynamic
- 7.5.2.2. Regulatory framework
- 7.5.2.3. Competitive insights
- 7.5.2.4. Japan Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.3. China
- 7.5.3.1. Key country dynamic
- 7.5.3.2. Regulatory framework
- 7.5.3.3. Competitive insights
- 7.5.3.4. China Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key country dynamic
- 7.5.4.2. Regulatory framework
- 7.5.4.3. Competitive insights
- 7.5.4.4. India Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.5. South Korea
- 7.5.5.1. Key country dynamic
- 7.5.5.2. Regulatory framework
- 7.5.5.3. Competitive insights
- 7.5.5.4. South Korea Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.6. Australia
- 7.5.6.1. Key country dynamic
- 7.5.6.2. Regulatory framework
- 7.5.6.3. Competitive insights
- 7.5.6.4. Australia Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.7. Thailand
- 7.5.7.1. Key country dynamic
- 7.5.7.2. Regulatory framework
- 7.5.7.3. Competitive insights
- 7.5.7.4. Thailand Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6. Latin America
- 7.6.1. Latin America Endobronchial ultrasound biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key country dynamic
- 7.6.2.2. Regulatory framework
- 7.6.2.3. Competitive insights
- 7.6.2.4. Brazil Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key country dynamic
- 7.6.3.2. Regulatory framework
- 7.6.3.3. Competitive insights
- 7.6.3.4. Argentina Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7. MEA
- 7.7.1. MEA Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Key country dynamic
- 7.7.2.2. Regulatory framework
- 7.7.2.3. Competitive insights
- 7.7.2.4. South Africa Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.3. Saudi Arabia
- 7.7.3.1. Key country dynamic
- 7.7.3.2. Regulatory framework
- 7.7.3.3. Competitive insights
- 7.7.3.4. Saudi Arabia Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key country dynamic
- 7.7.4.2. Regulatory framework
- 7.7.4.3. Competitive insights
- 7.7.4.4. UAE Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key country dynamic
- 7.7.5.2. Regulatory framework
- 7.7.5.3. Competitive insights
- 7.7.5.4. Kuwait Endobronchial ultrasound biopsy market estimates and forecasts, 2021 - 2033 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Participant Overview
- 8.2. Company Market Position Analysis
- 8.3. Company Categorization
- 8.4. Strategy Mapping
- 8.5. Company Profiles/Listing
- 8.5.1. GE Healthcare
- 8.5.1.1. Overview
- 8.5.1.2. Financial performance
- 8.5.1.3. Product Benchmarking (Variables: Manufacturer, Model, Outer Diameter - Tip/Insertion, Viewing Angle, Channel Ø, Notable Features)
- 8.5.1.4. Strategic initiatives
- 8.5.2. Siemens Healthcare Private Limited
- 8.5.2.1. Overview
- 8.5.2.2. Financial performance
- 8.5.2.3. Product Benchmarking (Variables: Manufacturer, Model, Outer Diameter - Tip/Insertion, Viewing Angle, Channel Ø, Notable Features)
- 8.5.2.4. Strategic initiatives
- 8.5.3. Koninklijke Philips N.V.
- 8.5.3.1. Overview
- 8.5.3.2. Financial performance
- 8.5.3.3. Product Benchmarking (Variables: Manufacturer, Model, Outer Diameter - Tip/Insertion, Viewing Angle, Channel Ø, Notable Features)
- 8.5.3.4. Strategic initiatives
- 8.5.4. Boston Scientific Corporation
- 8.5.4.1. Overview
- 8.5.4.2. Financial performance
- 8.5.4.3. Product Benchmarking (Variables: Manufacturer, Model, Outer Diameter - Tip/Insertion, Viewing Angle, Channel Ø, Notable Features)
- 8.5.4.4. Strategic initiatives
- 8.5.5. Olympus Corporation
- 8.5.5.1. Overview
- 8.5.5.2. Financial performance
- 8.5.5.3. Product Benchmarking (Variables: Manufacturer, Model, Outer Diameter - Tip/Insertion, Viewing Angle, Channel Ø, Notable Features)
- 8.5.5.4. Strategic initiatives
- 8.5.6. Cook Group Incorporated
- 8.5.6.1. Overview
- 8.5.6.2. Financial performance
- 8.5.6.3. Product Benchmarking (Variables: Manufacturer, Model, Outer Diameter - Tip/Insertion, Viewing Angle, Channel Ø, Notable Features)
- 8.5.6.4. Strategic initiatives
- 8.5.7. FUJIFILM Holdings Corporation
- 8.5.7.1. Overview
- 8.5.7.2. Financial performance
- 8.5.7.3. Product Benchmarking (Variables: Manufacturer, Model, Outer Diameter - Tip/Insertion, Viewing Angle, Channel Ø, Notable Features)
- 8.5.7.4. Strategic initiatives
- 8.5.8. Medi-Globe Technologies GmbH
- 8.5.8.1. Overview
- 8.5.8.2. Financial performance
- 8.5.8.3. Product Benchmarking (Variables: Manufacturer, Model, Outer Diameter - Tip/Insertion, Viewing Angle, Channel Ø, Notable Features)
- 8.5.8.4. Strategic initiatives
- 8.5.9. ACE Medical Devices Pvt. Ltd.
- 8.5.9.1. Overview
- 8.5.9.2. Financial performance
- 8.5.9.3. Product Benchmarking (Variables: Manufacturer, Model, Outer Diameter - Tip/Insertion, Viewing Angle, Channel Ø, Notable Features)
- 8.5.9.4. Strategic initiatives
- 8.5.10. Praxis Medical
- 8.5.10.1. Overview
- 8.5.10.2. Financial performance
- 8.5.10.3. Product Benchmarking (Variables: Manufacturer, Model, Outer Diameter - Tip/Insertion, Viewing Angle, Channel Ø, Notable Features)
- 8.5.10.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
